文献速递中枢神经肿瘤放疗

表皮生长因子受体突变胶质母细胞瘤中ZDHHC16介导的SETD2棕榈酰化促进电离辐射诱导的DNA损伤

SETD2 Palmitoylation Mediated by ZDHHC16 in Epidermal Growth Factor Receptor-Mutated Glioblastoma Promotes Ionizing Radiation-Induced DNA Damage.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-02-19

该研究探讨EGFR突变胶质母细胞瘤中ZDHHC16/SETD2/H3K36me3信号轴的作用。ZDHHC16在GBM中较正常脑组织下调且与EGFR改变显著相关,导致p53激活和G1/S期阻滞。去棕榈酰化抑制剂PalmB可能作为GBM放疗的潜在新型辅助治疗。

要点

  • ZDHHC16在GBM中较正常脑组织下调,且与EGFR改变显著相关
  • ZDHHC16/SETD2/H3K36me3信号轴在EGFR改变的GBM中失活
  • 去棕榈酰化抑制剂PalmB可能作为GBM放疗的潜在新型辅助治疗

核心结论

  • ZDHHC16/SETD2/H3K36me3信号轴在EGFR改变的GBM中失活,去棕榈酰化抑制剂PalmB可能作为接受放疗的GBM患者的潜在新型辅助治疗。

研究设计与样本

  • 采用生物信息学分析、蛋白质印迹、免疫荧光和免疫组化检测GBM中ZDHHC16表达及EGFR基因改变。
  • 通过多种体外实验(药物治疗、流式细胞术、Transwell迁移实验和免疫共沉淀)和体内实验(异种移植模型)验证EGFR改变后ZDHHC16/SETD2/H3K36me3信号轴的生物学功能。

主要发现

  • ZDHHC16在GBM中较正常脑组织下调,且与EGFR改变显著相关。
  • 上述事件促进p53激活,使细胞阻滞于G1/S检查点。
  • 电离辐射诱导DNA损伤后,EGFR扩增的GBM中DNA损伤修复信号通过SETD2棕榈酰化减少及其靶标H3K36甲基化降低而受到影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The prevalence of epidermal growth factor receptor (EGFR) mutations in glioblastoma multiforme (GBM) has elicited a significant focus on EGFR as a potential drug target. However, no significant clinical advancement in GBM treatment has occurred. METHODS AND MATERIALS: Bioinformatics analysis, western blotting, immunofluorescence, and immunohistochemistry were performed to detect the expression of ZDHHC16 and genetic EGFR alterations in GBM. The biological function of ZDHHC16/SETD2/H3K36me3 signaling axis after EGFR alterations was demonstrated by various in vitro (pharmacologic treatment, flow cytometry, transwell migration assay, and coimmunoprecipitation) and in vivo (xenograft model) experiments. RESULTS: We demonstrate that the ZDHHC16/SETD2/H3K36me3 signaling axis was inactivated in EGFR-altered GBM. ZDHHC16 was downregulated in GBM versus normal brain tissue; this was significantly related to EGFR alterations. These events contributed to p53 activation, halting cells at the G1/S checkpoint. Furthermore, DNA damage repair signaling in EGFR-amplified GBMs was affected after ionizing radiation-induced DNA damage via reduced SETD2 palmitoylation and methylation of its target, H3K36. Our findings suggest that a depalmitoylation inhibitor, PalmB, is useful as a potentially novel adjuvant treatment for patients with GBM undergoing radiation therapy. CONCLUSIONS: Our data present novel mechanistic evidence relating to signaling pathways with DNA damage responses in EGFR-mutated GBM.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Fan X, Sun S, Yang H, et al. SETD2 Palmitoylation Mediated by ZDHHC16 in Epidermal Growth Factor Receptor-Mutated Glioblastoma Promotes Ionizing Radiation-Induced DNA Damage. Int J Radiat Oncol Biol Phys. 2022. PMID: 35192890. doi:10.1016/j.ijrobp.2022.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。